Novel material advantage Leverage the Aguamedicina hydrogel technology as a differentiator in market segments seeking antifouling, patient-friendly ureteral stents and catheters, highlighting reduced biofilms and potential cost savings from fewer complications.

Endoscopy friendly Target urology clinics and hospitals with device designs that are softer, highly lubricious, and easily navigated through endoscope channels or urethral sheaths, enabling smoother procedures and faster patient turnover.

Positioned consolidation Emphasize the intellectual property and manufacturing approach where the hydrogel is the device material rather than a coating, appealing to buyers seeking innovative, durable solutions with potential regulatory and performance advantages.

Growth via integration Explore partnerships with large medical device distributors and adjacent ureteral stent/catheter portfolios to accelerate market penetration, leveraging the company’s small team to enable nimble commercialization while planning scale-up.

Clinical and cost benefits Highlight validated clinical usage showing improved patient comfort and diminished biofilms, framing the technology as a potential to reduce healthcare costs through fewer complications and streamlined device management.